Estrella Immunopharma Company Insiders
| ESLAW Stock | 0.1 0.01 14.29% |
Estrella Immunopharma employs about 2 people. The company is managed by 2 executives with a total tenure of roughly 5 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive. Recap of Estrella Immunopharma's management performance can provide insight into the venture performance.
Estrella |
Estrella Immunopharma Management Team Effectiveness
The company has return on total asset (ROA) of (1.7475) % which means that it has lost $1.7475 on every $100 spent on assets. This is way below average. Estrella Immunopharma's management efficiency ratios could be used to measure how well Estrella Immunopharma manages its routine affairs as well as how well it operates its assets and liabilities.Estrella Immunopharma Workforce Comparison
Estrella Immunopharma is one of the top stocks in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 20,257. Estrella Immunopharma adds roughly 2.0 in number of employees claiming only tiny portion of equities under Health Care industry.
Estrella Immunopharma Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Estrella Immunopharma Price Series Summation is a cross summation of Estrella Immunopharma price series and its benchmark/peer.
Estrella Immunopharma Notable Stakeholders
An Estrella Immunopharma stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Estrella Immunopharma often face trade-offs trying to please all of them. Estrella Immunopharma's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Estrella Immunopharma's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Cheng Liu | President CEO | Profile | |
| Jiandong Xu | Chief Officer | Profile |
About Estrella Immunopharma Management Performance
The success or failure of an entity such as Estrella Immunopharma often depends on how effective the management is. Estrella Immunopharma management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Estrella management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Estrella management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Please note, the imprecision that can be found in Estrella Immunopharma's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Estrella Immunopharma. Check Estrella Immunopharma's Beneish M Score to see the likelihood of Estrella Immunopharma's management manipulating its earnings.
Estrella Immunopharma Workforce Analysis
Traditionally, organizations such as Estrella Immunopharma use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Estrella Immunopharma within its industry.Estrella Immunopharma Manpower Efficiency
Return on Estrella Immunopharma Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 3.7M | |
| Net Loss Per Executive | 3.7M | |
| Working Capital Per Employee | 2.1M | |
| Working Capital Per Executive | 2.1M |
Additional Tools for Estrella Stock Analysis
When running Estrella Immunopharma's price analysis, check to measure Estrella Immunopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Estrella Immunopharma is operating at the current time. Most of Estrella Immunopharma's value examination focuses on studying past and present price action to predict the probability of Estrella Immunopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Estrella Immunopharma's price. Additionally, you may evaluate how the addition of Estrella Immunopharma to your portfolios can decrease your overall portfolio volatility.